Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?

Saved in:

Bibliographic Details
Main Authors:	Tan, Teng Hwee, Soon, Yu Yang, Cheo, Timothy, Wong, Lea Choung, Leong, Yiat Horng, Tey, Jeremy Chee Seong, Ho, Francis
Other Authors:	MEDICINE
Format:	Conference or Workshop Item
Published:	AMER SOC CLINICAL ONCOLOGY 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/245837
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-245837
record_format	dspace
spelling	sg-nus-scholar.10635-2458372024-11-13T20:22:05Z Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile? Tan, Teng Hwee Soon, Yu Yang Cheo, Timothy Wong, Lea Choung Leong, Yiat Horng Tey, Jeremy Chee Seong Ho, Francis MEDICINE Dr Lea Choung Wong Science & Technology Life Sciences & Biomedicine Oncology 38 29 2023-11-09T00:38:09Z 2023-11-09T00:38:09Z 2020-10-10 2023-11-08T09:08:50Z Conference Paper Tan, Teng Hwee, Soon, Yu Yang, Cheo, Timothy, Wong, Lea Choung, Leong, Yiat Horng, Tey, Jeremy Chee Seong, Ho, Francis (2020-10-10). Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile? 38 (29). ScholarBank@NUS Repository. 0732-183X 1527-7755 https://scholarbank.nus.edu.sg/handle/10635/245837 AMER SOC CLINICAL ONCOLOGY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Science & Technology Life Sciences & Biomedicine Oncology
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology Tan, Teng Hwee Soon, Yu Yang Cheo, Timothy Wong, Lea Choung Leong, Yiat Horng Tey, Jeremy Chee Seong Ho, Francis Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
description	38
author2	MEDICINE
author_facet	MEDICINE Tan, Teng Hwee Soon, Yu Yang Cheo, Timothy Wong, Lea Choung Leong, Yiat Horng Tey, Jeremy Chee Seong Ho, Francis
format	Conference or Workshop Item
author	Tan, Teng Hwee Soon, Yu Yang Cheo, Timothy Wong, Lea Choung Leong, Yiat Horng Tey, Jeremy Chee Seong Ho, Francis
author_sort	Tan, Teng Hwee
title	Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
title_short	Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
title_full	Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
title_fullStr	Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
title_full_unstemmed	Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
title_sort	applying the asco and esmo value frameworks to nasopharyngeal cancer treatments: is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
publisher	AMER SOC CLINICAL ONCOLOGY
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/245837
_version_	1821216776623489024

Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?

Similar Items